SEC Form 4 · accession 0001209191-16-151867
Corbus Pharmaceuticals Holdings, Inc. · CRBP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Yuval Cohen
Officer — Chief Executive Officer · Director
Period of report
Nov 22, 2016
Accepted (ET)
Nov 23, 2016 · 11:44 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001595097
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 22, 2016 | P | 1,340 | $7.64 | A | 12,830 | D |
Table II — derivative securities
No Table II lines on this filing.